Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
BetterLife Pharma
(OTCQB:BETRF)
Intraday
$0.0727
0.0008
[1.11%]
After-Hours
$0.0727
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0727
0.0008
[1.11%]
At close: Mar 6
$0.0727
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for BetterLife Pharma Stock (OTC:BETRF)
BetterLife Pharma Stock (OTC: BETRF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
-
Apr 17, 2024, 9:13AM
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
-
Mar 16, 2024, 9:58AM
Tuesday, July 04, 2023
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
Lara Goldstein
-
Jul 4, 2023, 10:21AM
Wednesday, June 28, 2023
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Lara Goldstein
-
Jun 28, 2023, 3:01PM
Tuesday, June 13, 2023
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
Lara Goldstein
-
Jun 13, 2023, 10:31AM
Friday, June 09, 2023
BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
Lara Goldstein
-
Jun 9, 2023, 4:45PM
Monday, March 13, 2023
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Lara Goldstein
-
Mar 13, 2023, 5:13PM
Thursday, March 09, 2023
Mood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic Psychedelic
Lara Goldstein
-
Mar 9, 2023, 2:44PM
Thursday, January 26, 2023
BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
Lara Goldstein
-
Jan 26, 2023, 1:02PM
Tuesday, September 27, 2022
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
Lara Goldstein
-
Sep 27, 2022, 5:57PM
Wednesday, August 24, 2022
Study Reveals LSD May Boost Memory And Performance Without Those Hallucinating Side Effects
Lara Goldstein
-
Aug 24, 2022, 3:18PM
Wednesday, July 06, 2022
BetterLife's Preclinical Studies Of BETR-001 For Depression Gets Additional Sponsorship By Mitacs
Lara Goldstein
-
Jul 6, 2022, 1:58PM
Monday, November 15, 2021
EXCLUSIVE: Can Non-Hallucinogenic Psychedelic Compounds Treat Mental Health Conditions? This Company Thinks So!
Jacinta Sherris
-
Sponsored
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
-
Oct 18, 2021, 1:37PM
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
-
Oct 13, 2021, 4:25PM
Wednesday, August 11, 2021
What Do You Really Know About Psychedelics And Psychedelics Stocks?
Jeff Siegel
-
Aug 11, 2021, 11:18AM
Tuesday, April 06, 2021
Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
Natan Ponieman
-
Apr 6, 2021, 11:39AM
Tuesday, March 30, 2021
Why Would Anyone Invest In The Psychedelics Medicine Market? 


Jeff Siegel
-
Mar 30, 2021, 1:07PM
Monday, February 08, 2021
Cannabis Stock Gainers And Losers From February 8, 2021
Jose Rodrigo Safdiye
-
Feb 8, 2021, 5:19PM
Tuesday, January 05, 2021
Why The Psychedelics Market Is NOT Cannabis 2.0
Jeff Siegel
-
Jan 5, 2021, 2:24PM
Monday, December 14, 2020
Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia
Natan Ponieman
-
Dec 14, 2020, 10:03AM